Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Tacrine Hydrochloride Hydrate: From Target to Translation
2026-09-16
Tacrine hydrochloride hydrate, also known as Tetrahydroaminacrine, is more than a historical acetylcholinesterase inhibitor. This thought-leadership perspective shows how its dual-site cholinesterase pharmacology, neuroprotective hypotheses, and well-defined translational liabilities can guide rigorous Alzheimer’s disease research, assay design, and next-generation multi-target discovery.
-
RNA Pol II Degradation Activates Apoptotic Signaling
2026-09-16
Harper et al. show that RNA polymerase II inhibition kills cells through an active apoptotic response to depletion of hypophosphorylated RNA Pol IIA, rather than through passive loss of transcription and mRNA. Their combination of rescue experiments, functional genomics, and chemogenetic profiling defines the Pol II degradation-dependent apoptotic response and provides a framework for interpreting cytotoxicity from transcription-targeting therapies.
-
Sumatriptan as an Anti-Inflammatory Agent
2026-09-15
This systematic review reframes sumatriptan as more than an acute antimigraine drug by synthesizing evidence for anti-inflammatory, neuropeptide, nitric oxide, and cell-survival effects. Its findings support cautious drug-repositioning research while emphasizing that most evidence comes from experimental models rather than definitive clinical trials.
-
Polymyxin B: Decoding LPS–Immune Signaling
2026-09-15
Polymyxin B sulfate is more than a bactericidal reagent: it can serve as a mechanistic probe of membrane disruption, LPS activity, and immune assay interpretation. This article connects Polymyxin B workflows with new evidence on hexa-acylated LPS and cancer immunotherapy response.
-
Ozone, Efferocytosis, and Neuropathic Pain
2026-09-14
A 2024 Frontiers in Immunology study shows that ozone reduces neuropathic pain in a chronic constriction injury model while enhancing macrophage clearance of apoptotic cells. The results connect AMPK activation with the Gas6–MerTK–SOCS3 axis and provide a mechanistic framework for studying efferocytosis as a regulator of neuroinflammation.
-
Vincristine Sulfate: Applied Research Workflows
2026-09-14
Build more reproducible microtubule-disruption assays with Vincristine sulfate, from stock preparation and dose-response design to imaging and cytotoxicity validation. This guide also shows how a systematic-review framework can improve endpoint selection without overstating evidence for inflammatory effects.
-
ECL Chemiluminescent Substrate Detection Kit Guide
2026-09-13
Use hypersensitive HRP chemiluminescence to resolve low-abundance pathway proteins in metabolic disease models, including adipose-tissue signaling studies. This workflow emphasizes membrane choice, antibody economy, exposure control, and reproducible interpretation alongside microbiota and metabolomics data.
-
MnTBAP Chloride: From Redox Biology to Translation
2026-09-12
MnTBAP Chloride offers a mechanism-led way to interrogate how mitochondrial superoxide connects oxidative stress with inflammation, mitochondrial dysfunction, and stress-related phenotypes. This article places the compound’s endothelial, inflammatory, and chronic-stress evidence into a translational framework for designing stronger preclinical studies.
-
Ceftolozane Sulfate: Assay-to-PK/PD Workflow
2026-09-11
Build a practical pipeline from broth microdilution and time-kill testing to neutropenic mouse thigh infection model design with Ceftolozane sulfate. The workflow emphasizes isolate-specific MIC interpretation, AmpC-aware resistance analysis, and exposure targets based on free-drug time above MIC.
-
Chlorambucil: Reading DNA Damage in Cell Assays
2026-09-11
Chlorambucil is a nitrogen mustard alkylating agent whose effects can be misread when growth inhibition is treated as equivalent to cell death. This article applies a response-phenotyping framework to improve DNA damage, apoptosis, and cytotoxicity assay interpretation across cancer models.
-
Palonosetron and Chemotherapy-Induced Nausea
2026-09-10
Ruhlmann and Herrstedt’s review examines how palonosetron’s long receptor residence, high 5-HT3 affinity, allosteric binding, and positive cooperativity may influence prevention of chemotherapy-induced nausea and vomiting. Its central practical message is that pharmacologic distinctions matter only when they improve control of acute or delayed symptoms, tolerability, or treatment implementation.
-
Indazole and Indole Glucagon Receptor Antagonists
2026-09-10
The 2015 Bioorganic & Medicinal Chemistry Letters study describes a novel indazole- and indole-based series of glucagon receptor antagonists derived from the earlier MK-0893 program. Systematic SAR exploration produced compounds with strong in vitro activity, favorable rat pharmacokinetics, and oral efficacy for GRA 16d in humanized glucagon receptor mouse models.
-
ECL Chemiluminescent Substrate Detection Kit
2026-09-09
The hypersensitive ECL Chemiluminescent Substrate Detection Kit supports low-abundance protein analysis when conventional western blot signals are difficult to resolve. Its low-picogram sensitivity, reduced background, and extended signal window make it especially useful for validating inflammatory pathway proteins alongside RNA-focused experiments.
-
Reactive Oxygen Species Assay Kit: DHE Workflow
2026-09-09
Build a practical live-cell superoxide workflow around the Reactive Oxygen Species Assay Kit (DHE), from plate setup to signal normalization and troubleshooting. The approach translates shionone–mitophagy findings in pulmonary fibrosis into testable oxidative-stress experiments without treating fluorescence as a stand-alone proof of mechanism.
-
Podophyllotoxin Assay Workflows That Reproduce
2026-09-08
A scenario-driven guide to improving cell viability, proliferation, and cytotoxicity assays with Podophyllotoxin SKU N1790. It connects compound handling, microtubule-directed biology, orthogonal readouts, and practical vendor-selection criteria for more interpretable cancer research data.